ESPOSITO, Carla
 Distribuzione geografica
Continente #
NA - Nord America 5.803
AS - Asia 2.484
EU - Europa 1.972
SA - Sud America 232
AF - Africa 14
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.511
Nazione #
US - Stati Uniti d'America 5.732
HK - Hong Kong 1.135
CN - Cina 518
IT - Italia 498
UA - Ucraina 493
SG - Singapore 396
DE - Germania 262
VN - Vietnam 228
RU - Federazione Russa 218
BR - Brasile 214
FI - Finlandia 154
IE - Irlanda 139
TR - Turchia 78
SE - Svezia 70
FR - Francia 48
KR - Corea 42
MX - Messico 32
IN - India 31
CA - Canada 29
GB - Regno Unito 28
CZ - Repubblica Ceca 13
BD - Bangladesh 9
IQ - Iraq 9
ES - Italia 8
PL - Polonia 8
AT - Austria 6
IL - Israele 6
PK - Pakistan 6
AR - Argentina 5
ZA - Sudafrica 5
JP - Giappone 4
PH - Filippine 4
RS - Serbia 4
AL - Albania 3
CL - Cile 3
CO - Colombia 3
JO - Giordania 3
MA - Marocco 3
NL - Olanda 3
UZ - Uzbekistan 3
VE - Venezuela 3
AU - Australia 2
BG - Bulgaria 2
EC - Ecuador 2
HN - Honduras 2
JM - Giamaica 2
KE - Kenya 2
LT - Lituania 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RO - Romania 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CY - Cipro 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
RW - Ruanda 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TV - Tuvalu 1
TW - Taiwan 1
TZ - Tanzania 1
VC - Saint Vincent e Grenadine 1
Totale 10.511
Città #
Ann Arbor 1.338
Hong Kong 1.135
Wilmington 691
Chandler 619
Jacksonville 596
Princeton 393
Houston 260
Dong Ket 210
Woodbridge 209
Ashburn 192
Dallas 181
Singapore 174
Munich 139
Dublin 136
Boardman 111
Nanjing 110
Dearborn 107
Beijing 106
Andover 97
Pellezzano 76
Salerno 65
Izmir 62
Mestre 49
Moscow 49
Fairfield 41
Helsinki 40
Redwood City 37
Nanchang 35
Hebei 33
Shenyang 33
Changsha 27
Tianjin 21
Jiaxing 20
Los Angeles 20
São Paulo 20
Pune 19
Napoli 16
Sant'agata De' Goti 16
Washington 15
Cuauhtémoc 14
Agropoli 13
Brno 12
New York 12
Norwalk 12
Cava 11
Düsseldorf 11
Ottawa 11
San Diego 11
Turku 11
Belo Horizonte 10
Brooklyn 10
Guangzhou 9
Istanbul 9
Lessolo 9
Montreal 9
Phoenix 9
Seattle 9
Naples 8
Potenza 8
Rio de Janeiro 8
Santa Clara 8
Spinea 8
The Dalles 8
Warsaw 8
Bari 7
Boston 7
Caserta 7
Council Bluffs 7
Jinan 6
Kunming 6
Marsico Nuovo 6
Stockholm 6
Bologna 5
Chicago 5
Hefei 5
Portici 5
San Francisco 5
Shanghai 5
Springfield 5
Vienna 5
Atlanta 4
Belgrade 4
Brasília 4
Cambridge 4
Columbus 4
Curitiba 4
Dormagen 4
Guarulhos 4
Ho Chi Minh City 4
La Paz 4
Lequile 4
London 4
Tokyo 4
Venezia 4
Zhengzhou 4
Amman 3
Ankara 3
Buffalo 3
Charlotte 3
Chennai 3
Totale 7.913
Nome #
Searching for the protein targets of 4-nonylphenol using a computational approach 459
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells 404
A preliminary study on nonylphenol toxicity in human intestinal epithelial cells 299
Searching for the protein targets of 4-nonylphenol using a computational approach 223
The surfactant 4-nonylphenol is cytotoxic for cells of the human gastrointestinal tract. 182
Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases. 160
Analysis of transglutaminase protein substrates by functional proteomics. 153
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease. 150
4-Nonylphenol reduces cell viability and induces apoptosis and ER-stress in a human epithelial intestinal cell line 150
An acetic acid-based extraction method to obtain high quality collagen from archeological bone remains 147
Celiac anti‑type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects 146
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells 140
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca(2+) homeostasis 135
The toxic alpha-gliadin peptide 31-43 enters cells without a surface membrane receptor 132
Antibodies against type 2 transglutaminase modulate actin rearrangements and cell cycle in several cell lines 131
Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics 128
Application of a computational approach to identify protein targets for 4-nonylphenol 128
Enzymatic Strategies to Detoxify Gluten:Implications for Celiac Disease 121
THE A-GLIADIN PEPTIDE 31-43 INDUCES NF-kB ACTIVATION AND MODULATE TYPE 2 TRANSGLUTAMINASE ACTIVITY IN AN INTESTINAL EPITHELIAL CELL LINE 121
Synthesis of peptidocalix[4]arene diversomers as transglutaminase inhibitors by protein surface recognition 118
Chronic Exposure to Cadmium Disrupts the Adrenal Gland Activity of the Newt Triturus carnifex (Amphibia, Urodela) 116
Tissue transglutaminase in celiac disease: role of autoantibodies. 115
Celiac autoantibodies to tissue transglutaminase modulate alpha-gliadin peptide uptake by epithelial cells 115
ANTI-TISSUE TRANSGLUTAMINASE ANTIBODIES ACTIVATE CYTOSOLIC TISSUE TRANSGLUTAMINASE BY MOBILIZING CALCIUM IONS FROM INTRACELLULAR STORES 115
Identification of differential phosphorylated proteins in Caco-2 cells treated with anti-tissue transglutaminase antibodies 115
Gliadin Peptides Induce Tissue Transglutaminase Activation and ER-Stress through Ca(2+) Mobilization in Caco-2 Cells. 114
Autoantibodies to tissue transglutaminase can induce ER (endoplasmic reticulum) stress response in Caco-2 cells 113
Interaction of 'toxic' and 'immunogenic' A-gliadin peptides with a membrane-mimetic environment 110
Serum IgA and IgG and intestinal monoclonal anti-tissue transglutaminase antibodies from coeliac patients inhibit the catalytic activity both in vitro and in situ. 106
Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease 104
Anti-Tissue Transglutaminase Antibodies from Coeliac Patients Inhibit Transglutaminase Activity both in Vitro and in Situ 103
A-gliadin peptide 31-43 induces NF-κB and tissue transglutaminase activation in an intestinal epithelial cell line 103
Internalization of alpha gliadin peptide 31-43 by Caco-2 cells does not require a surface receptor. 101
New therapeutic strategies for coeliac disease: tissue transglutaminase as a target 101
Biochemical characterization of recombinant rat prostate transglutaminase expressed into MDCK cells 100
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies. 100
Mammalian Transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance. 99
null 98
Expression and enzymatic activity of small intestinal tissue transglutaminase in coeliac disease 98
Tissue transglutaminase autoantibodies regulate actin rearrangements and cell cycle in several cell types 98
N-terminus end of rat prostate transglutaminase is responsible for its catalytic activity and GTP binding 97
Subcellular distribution of type 2 transglutaminase is constitutively different in skin derived-fibroblasts from celiac disease patients and from healthy controls 96
Anti-tissue transglutaminase antibodies have biological effects on cultured intestinal biopsies from celiac patients 95
Histological changes, apoptosis and metallothionein levels in Triturus carnifex (Amphibia, Urodela) exposed to environmental cadmium concentrations 95
Transglutaminase 2 in celiac diasease: Minireview article 94
Caratterizzazione della transglutaminasi da prostata di ratto espressa in cellule MDCK 94
A-GLIADIN PEPTIDES INDUCE TISSUE TRANSGLUTAMINASE ACTIVATION THROUGH CA2+ MOBILIZATION IN CACO-2 CELLS 91
GTPase and transglutaminase are associated in the secretion of rat anterior prostate. 90
Celiac anti-tissue transglutaminase antibodies derange alpha gliadin peptide 31-43 uptake by epithelial cells. 90
Tissue Transglutaminase and Coeliac Disease. 88
Transglutaminase surface recognition by peptidocalix[4]arene diversomers. 88
Type 2 transglutaminase contributes to define a cellular phenotype typical of celiac cells. 88
Proteomics identification of acyl-acceptor and acyl-donor substrates for transglutaminase in a human intestinal epithelial cell line: implications for coeliac disease. 86
Expression and Enzymatic Activity of Small Intestinal Tissue Transglutaminase in Coeliac Disease 84
Tissue transglutaminase modulators regulate actin rearrangements and cell cycle in several cell types 83
Seminal Vesicle Protein IV and Its Derived Active Peptides: A Possible Physiological Role in Seminal Clotting. 83
Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate deydrogenase and polyglutamine repeat. 83
The monoclonal anti-tissue transglutaminase antibody CUB 7402 reduces the alpha-gliadin peptides uptake by Caco-2 cells 82
Tissue transglutaminase is implicated in the antiproliferative and proapoptotic effect induced by the histone deacetylase inhibitor 81
Studi di specificità di isoforme dell'enzima transglutaminasi per modificare proteine del latte 81
Celiac anti-tissue transglutaminase autoantibodies interfere with the ability of alpha-gliadin peptide 31-43 to drive intestinal epithelial cells into S-phase. 81
The Pituitary-adrenal gland Activity of Triturus carnifex (Amphibia, Urodela) exposed to Environmental Cadmium Concentrations 81
Identification of acyl-acceptor and acyl-donor substrates for transglutaminase in CaCo-2 intestinal cell line: implications for coeliac disease 80
Non celiac patients’ anti-tissue transglutaminase antibodies: immunological and functional characterization. 80
Constitutive differential features of type 2 transglutaminase in cells derived from celiac patients and from healthy subjects 79
Studio del riconoscimento tra transglutaminasi di tipo 2 e auto-anticorpi anti-transglutaminasi caratteristici della malattia celiaca 78
Influenza delle modifiche post-traduzionali sulle proprietà biologiche della TGasi presente nel secreto della ghiandola coagulatoria 77
Serum immunoglobulin A and G and monoclonal antibodies anti tissue-transglutaminase from coeliac patients inhibit the catalytic activity both in vitro and in situ. 77
Transglutaminase-mediated amine incorporation into substance P protects the peptide against proteolysis in vitro. 74
Interaction of “toxic” and “immunogenic” A-gliadin peptides with a membrane-like environment in vitro. 74
Transglutaminase surface recognition by peptidocalix[4]arene diversomers 73
Interplay between type 2 transglutaminase (Tg2), gliadin peptide 31-43 and anti-tg2 antibodies in celiac disease 72
null 71
Effects of Methyl Bromide on activity of blood coagulation enzymes 71
Transglutaminase-synthesized analogs of substance P is a selective tool for neurokinin-2 receptors. 70
Role of type 2 transglutaminase autoantibodies in phatogenesis of celiac disease 70
Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells 69
Substance P and its transglutaminase-synthesized spermine derivative elicit yawning behavior via nitric oxide in rats. 69
Rat coagulating gland secretion contains a kinesin heavy chain-like protein acting as type IV transglutaminase substrate 69
Studies on transglutaminase type IV in relation to proteins occuring in rat coagulating gland secretion 69
Transglutaminase-synthesized spermine derivative of substance P recognizes rat portal vein neurokinin-3 receptors. 69
Implication of cell-surface transglutaminase in gliadin peptides uptake by Caco-2 cells 69
Riconoscimento di superficie delle transglutamminasi mediante diversomeri peptidocalix[4]arenici 68
Characterisation of rat coagulating gland transglutaminase expressed in heterologous cell systems 67
Do tissue transglutaminase antibodies contribute to the intestinal lesion in celiac disease? 67
null 67
Identification of tissue transglutaminase-reactive lysine residues in glyceraldheide-3-phosphate dehydrogenase 65
Tissue transglutaminase autoantibodies regulate actin rearrangements and cell cycle in several cell types. 65
Implication of tissue transglutaminase and desmoplakin in cell adhesion mechanism in human epidermis 64
Enzymatic synthesis of vasoactive intestinal peptide analogs by transglutaminase. 63
Transglutaminase-mediated polyamination of vasoactive intestinal peptide (VIP) Gln16 residue modulates the VIP/PACAP receptor activity. 61
Desmoplakin acts as transglutaminase substrate in vitro. 61
IgA e IgG sieriche e anticorpi monoclonali intestinali anti-transglutaminasi tissutale ottenuti da pazienti celiaci inibiscono l'attività catalitica sia in vitro che in situ 61
Protein SV-IV promotes nitric oxide production not associated with apoptosis in murine macrophages. 60
Overlapping between fluorescence modifications and activation of prostate transglutaminase induced by sodium dodecylsulphate. 59
Expression and enzymatic activity of transglutaminase in the normal and coeliac small intestinal mucosa 59
Espressione e attività enzimatica della transglutaminasi tissutale nella mucosa intestinale di pazienti celiaci 59
Structural characterisation of transglutaminase-catalysed protein aggregates correlated to neurodegenerative disorders. 57
Coeliac disease and extraintestinal autoimmunity. 56
Rat prostate transglutaminase: biochemical properties of recombinant forms expressed into COS-1 cells 55
Totale 10.256
Categoria #
all - tutte 34.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.171


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021884 0 0 107 5 132 37 112 9 132 13 115 222
2021/2022769 0 0 4 2 40 13 1 25 114 87 121 362
2022/20231.343 134 103 31 176 186 260 0 166 196 0 64 27
2023/2024465 48 68 33 21 38 81 23 31 0 26 19 77
2024/20251.308 62 27 54 88 58 147 268 146 183 33 112 130
2025/20261.529 540 980 9 0 0 0 0 0 0 0 0 0
Totale 10.721